CCL Products
CCL Products
Consumer GoodsKey Fundamentals
MicrocapTea & CoffeeConsumer GoodsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company has reduced debt.
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 21.8%
Weaknesses
1- Stock is trading at 6.02 times its book value
Growth Rate
AI Analysis — Bull vs Bear
CCL Products (India) Ltd, with a market cap of ₹14,318 Cr, is the world's largest private-label instant coffee manufacturer. The company trades at a P/E of 32.8x and P/B of 6.05x, with TTM sales growth of 36% and profit growth of 39%, while maintaining an ROE of 18% over the last year.
- TTM revenue growth of 36% significantly outpaces the 10-year compounded sales CAGR of 17%, indicating an acceleration in top-line momentum
- TTM profit growth of 39% exceeds sales growth of 36%, suggesting improving operating leverage and margin expansion
- Consistent ROE of 17-18% across 3-year, 5-year, and 10-year periods reflects durable capital efficiency and stable return generation
- Company has been actively reducing debt, strengthening the balance sheet and lowering financial risk going forward
- 5-year compounded sales CAGR of 29% demonstrates sustained long-term demand tailwinds in the global instant coffee market
- Stock has delivered a 5-year price CAGR of 22%, outperforming many consumer goods peers, reflecting consistent market re-rating
- Healthy dividend payout ratio of 21.8% with a yield of 0.54% signals management confidence in cash flow sustainability
- Company is expected to deliver a strong upcoming quarter, which could provide near-term earnings catalyst
- P/B ratio of 6.05x is elevated for a consumer goods manufacturer, leaving limited margin of safety if growth slows
- P/E of 32.8x prices in significant future growth — any miss on the 36% TTM sales growth trajectory could trigger a de-rating
- 3-year compounded profit CAGR of only 11% lags the 3-year sales CAGR of 29%, raising questions about historical margin consistency
- 10-year profit CAGR of 12% is notably lower than the 10-year sales CAGR of 17%, indicating long-term earnings conversion has been sub-optimal
- Dividend yield of just 0.54% offers minimal income cushion during any period of capital depreciation
- 1-year stock price CAGR of 21% already reflects much of the recent operational improvement, potentially limiting near-term upside
- As a commodity-linked business, CCL remains exposed to global green coffee price volatility and INR/USD currency fluctuations that can compress margins unpredictably
- 5-year profit CAGR of 16% versus 5-year sales CAGR of 29% shows nearly half the revenue growth has not translated into proportional bottom-line gains over medium term
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Dividend approved at AGM Sep 08
CCL Products shareholders approved a ₹3.00 per share final dividend for FY26 at the 65th AGM on September 8, 2026. Two retiring directors were also re-elected with near-universal voting participation.
TL;DR: CCL Products held a routine but well-attended AGM, approving a steady ₹3.00/share dividend for FY26 and re-electing board members. No headwinds emerged from the single available update. With only one data point, the picture is incomplete, but the dividend payout signals management confidence in near-term cash flows.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 655 | 608 | 664 | 727 | 773 | 738 | 758 | 836 | 1,056 | 1,127 | 1,051 | 1,224 | 1,200 |
| Expenses | 549 | 498 | 554 | 609 | 643 | 601 | 634 | 673 | 897 | 930 | 866 | 1,033 | 1,007 |
| Operating Profit | 106 | 110 | 111 | 118 | 130 | 137 | 124 | 163 | 159 | 197 | 185 | 192 | 194 |
| OPM % | 16% | 18% | 17% | 16% | 17% | 19% | 16% | 20% | 15% | 18% | 18% | 16% | 16% |
| Other Income | 0 | 1 | 1 | 4 | 1 | 1 | 3 | 4 | 2 | 1 | 3 | 2 | 3 |
| Interest | 15 | 18 | 23 | 21 | 21 | 27 | 31 | 34 | 34 | 33 | 32 | 30 | 29 |
| Depreciation | 22 | 23 | 22 | 31 | 23 | 24 | 25 | 27 | 34 | 39 | 39 | 40 | 39 |
| PBT | 69 | 70 | 67 | 70 | 87 | 87 | 72 | 106 | 94 | 127 | 116 | 123 | 129 |
| Tax % | 13% | 13% | 5% | 7% | 18% | 15% | 12% | 4% | 23% | 21% | 14% | 7% | 9% |
| Net Profit | 61 | 61 | 63 | 65 | 71 | 74 | 63 | 102 | 72 | 101 | 100 | 115 | 117 |
| EPS in Rs | 4.56 | 4.57 | 4.76 | 4.88 | 5.35 | 5.54 | 4.72 | 7.63 | 5.43 | 7.55 | 7.51 | 8.58 | 8.75 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 881 | 932 | 976 | 1,138 | 1,081 | 1,139 | 1,242 | 1,462 | 2,071 | 2,654 | 3,106 | 4,457 | 4,602 |
| Expenses | 709 | 727 | 744 | 899 | 836 | 853 | 945 | 1,131 | 1,671 | 2,208 | 2,551 | 3,723 | 3,835 |
| Operating Profit | 171 | 205 | 232 | 239 | 245 | 286 | 298 | 331 | 400 | 445 | 555 | 734 | 767 |
| OPM % | 19% | 22% | 24% | 21% | 23% | 25% | 24% | 23% | 19% | 17% | 18% | 16% | 17% |
| Other Income | 3 | 1 | 1 | 5 | 3 | 4 | 3 | 4 | 3 | 6 | 8 | 7 | 9 |
| Interest | 14 | 11 | 11 | 8 | 8 | 18 | 17 | 16 | 34 | 78 | 113 | 129 | 124 |
| Depreciation | 27 | 28 | 33 | 34 | 32 | 47 | 49 | 57 | 64 | 98 | 98 | 152 | 157 |
| PBT | 134 | 167 | 189 | 202 | 209 | 225 | 235 | 261 | 305 | 276 | 352 | 461 | 496 |
| Tax % | 30% | 27% | 29% | 27% | 26% | 26% | 22% | 22% | 7% | 9% | 12% | 16% | — |
| Net Profit | 94 | 122 | 135 | 148 | 155 | 166 | 182 | 204 | 284 | 250 | 310 | 388 | 433 |
| EPS in Rs | 7.06 | 9.18 | 10.12 | 11.14 | 11.64 | 12.47 | 13.7 | 15.36 | 21.35 | 18.73 | 23.24 | 29.07 | 32.39 |
| Div. Payout % | 21% | 27% | 25% | 22% | 30% | 40% | 29% | 33% | 26% | 24% | 22% | 20% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 395 | 483 | 602 | 713 | 812 | 902 | 1,061 | 1,224 | 1,471 | 1,647 | 1,941 | 2,318 |
| Borrowings | 229 | 210 | 142 | 311 | 416 | 469 | 559 | 655 | 920 | 1,622 | 1,815 | 1,324 |
| Other Liabilities | 111 | 81 | 78 | 83 | 166 | 112 | 142 | 164 | 180 | 240 | 459 | 657 |
| Total Liabilities | 762 | 801 | 848 | 1,134 | 1,422 | 1,509 | 1,788 | 2,070 | 2,597 | 3,536 | 4,241 | 4,326 |
| Fixed Assets | 340 | 417 | 393 | 371 | 383 | 724 | 798 | 882 | 1,257 | 1,252 | 1,622 | 2,027 |
| CWIP | 53 | 0 | 0 | 226 | 424 | 100 | 149 | 160 | 54 | 501 | 450 | 3 |
| Investments | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 3 |
| Other Assets | 367 | 382 | 453 | 535 | 613 | 684 | 841 | 1,028 | 1,286 | 1,783 | 2,169 | 2,293 |
| Total Assets | 762 | 801 | 848 | 1,134 | 1,422 | 1,509 | 1,788 | 2,070 | 2,597 | 3,536 | 4,241 | 4,326 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 105 | 161 | 102 | 145 | 162 | 91 | 171 | 116 | 173 | 55 | 290 | 858 |
| Investing | -19 | -87 | -20 | -247 | -175 | -88 | -153 | -192 | -307 | -527 | -415 | 18 |
| Financing | -93 | -82 | -84 | 129 | 42 | -37 | 64 | 9 | 164 | 559 | 53 | -757 |
| Net Cash Flow | -8 | -8 | -2 | 27 | 29 | -35 | 82 | -67 | 30 | 86 | -72 | 120 |
| Free Cash Flow | 84 | 74 | 84 | -78 | -80 | 2 | 16 | -74 | -159 | -458 | -128 | 788 |
| CFO/OP | 86 | 97 | 67 | 84 | 89 | 50 | 66 | 47 | 52 | 19 | 57 | 123 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 50 | 61 | 58 | 79 | 86 | 88 | 80 | 78 | 68 | 81 | 67 |
| Inventory Days | 116 | 99 | 121 | 97 | 123 | 170 | 198 | 262 | 187 | 185 | 208 | 131 |
| Days Payable | 29 | 8 | 8 | 5 | 35 | 16 | 13 | 23 | 24 | 23 | 44 | 32 |
| Cash Conversion Cycle | 134 | 142 | 174 | 150 | 168 | 240 | 272 | 319 | 241 | 230 | 246 | 166 |
| Working Capital Days | 45 | 37 | 81 | 89 | 43 | 103 | 59 | 77 | 58 | 40 | 42 | 41 |
| ROCE % | 23% | 26% | 27% | 23% | 19% | 18% | 17% | 16% | 16% | 12% | 13% | 16% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view CCL Products insights
60 extracted metrics + investor summaries across FY08–FY27.
Documents
Frequently Asked Questions about CCL Products
What does CCL Products (India) Ltd do?
Where is CCL Products (India) Ltd (CCL) listed?
Which sector does CCL Products (India) Ltd belong to?
What is the market capitalisation of CCL Products (India) Ltd?
What is the PE ratio of CCL Products (India) Ltd?
What is the 52-week high and low of CCL Products (India) Ltd?
Does CCL Products (India) Ltd pay dividends?
What is the Return on Equity (ROE) of CCL Products (India) Ltd?
Company Information
CCL Products (India) is engaged in the production, trading and distribution of Coffee. The Company has business operations mainly in India, Vietnam and Switzerland countries.(Source : 202003 Annual Report Page No:119)
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CCL.md for CCL Products (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.